10:44 AM
 | 
Jul 11, 2018
 |  BC Extra  |  Company News

Shanghai Junshi licenses anti-PD-1 mAb to CSPC

Shanghai Junshi Biosciences Co. Ltd. (Shanghai, China) granted CSPC Pharmaceutical Group Ltd. (HKSE:1093) exclusive rights in China,...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >